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ABSTRACT
Human aging is linked to many prevalent diseases. The aging process is highly influenced by genetic
factors. Hence, it is important to identify human aging-related genes. We focus on supervised
prediction of such genes. Gene expression-based methods for this purpose study genes in isolation
from each other. While protein-protein interaction (PPI) network-based methods for this purpose
account for interactions between genes’ protein products, current PPI network data are context-
unspecific, spanning different biological conditions. Instead, here, we focus on an aging-specific
subnetwork of the entire PPI network, obtained by integrating aging-specific gene expression data
and PPI network data. The potential of such data integration has been recognized but mostly in the
context of cancer. So, we are the first to propose a supervised learning framework for predicting
aging-related genes from an aging-specific PPI subnetwork. We find that using an aging-specific
subnetwork indeed yields more accurate aging-related gene predictions than using the entire network.
Also, predictive methods from our framework that have not previously been used for supervised
prediction of aging-related genes outperform existing prominent methods for the same purpose. These
results justify the need for our framework.
Keywords Biological networks, context-specific subnetworks, aging, node representations/features, node classification.
1 Introduction
1.1 Motivation and related work
Human aging poses a risk for many prevalent complex diseases, such as diabetes, cancer, osteoarthritis, and cardiovas-
cular or Alzheimer’s disease [1]. To better understand such diseases, it is important to study the aging process in human.
This process is known to be highly influenced by genetic factors. Consequently, lots of effort has gone into identifying
aging-related genes [2, 3]. Doing this via wet lab experiments is hard because of ethical constraints and long human life
span [4]. So, computational identification (i.e., prediction) of aging-related genes has received significant attention.
This strategy uses features of genes extracted from some (e.g., gene expression or protein-protein interaction (PPI) data)
data via unsupervised [5, 6] or supervised [3, 7, 8] learning to predict genes that are most likely to be aging-related.
Unsupervised and supervised learning differ in that the former does not consider current knowledge about aging when
making predictions but instead considers it only when evaluating the predictions. The latter considers a part of the
current knowledge when making predictions and its other part when evaluating the predictions. Both have advantages.
Here, we focus on supervised learning, to benefit from the current knowledge while predicting new knowledge about
aging.
There exits two major methodological directions for computationally predicting human aging-related genes: i) from
model species to human and ii) within the human species. The former predicts a gene in human to be aging-related if its
sequence [9] or its PPI network neighborhood [10,11] is aligned to that of an aging-related gene in a model species. The
latter predicts a gene in human to be aging-related if it is “similar” (see below) to known aging-related genes in human.
Both directions are important. They are simply different. Here, we focus on the latter. Methods of this type can be
further divided into two major groups: gene expression-based ones [12–16] and PPI network-based ones [3, 8, 17–19],
as follows.
Gene expression-based methods predict a gene as aging-related if it is differentially expressed between younger age
versus older age, or if its expression value either increases or decreases with age when dealing with more than two
ages [12–16]. A limitation of gene expression-based methods is that they study genes in isolation from each other.
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However, cellular processes, including aging, are carried out by genes’ protein products interacting with each other in
complex ways [20]. So, it is essential to consider interactions between proteins.
This is exactly what PPI network-based methods do. They predict a gene as aging-related according to how similar
its position (i.e., node representation/embedding/feature) in the PPI network is to the network positions of known
aging-related genes [7, 8, 17, 18]. State-of-the-art approaches of this type are UniNet [8] and mBPIs [7]. UniNet’s
feature concatenates 14 network centrality measures (e.g., degree or betweenness), where centrality of a node captures
its importance in the network. The feature of mBPIs is constructed as follows. First, m nodes with the highest degrees
in the network are identified. Then, for each node v in the network, v’s feature has m dimensions corresponding to
the top m highest-degree nodes, where each dimension j of node v’s feature indicates whether v interacts with the top
m highest-degree node j. A limitation of these and other PPI network-based methods is that the current PPI network
data are context-unspecific, meaning that the PPIs span different conditions (cell types, tissues, diseases, environments,
patients, etc.) [21]; consequently, the current PPI network data are also static [4]. We argue that it is essential to consider
aging-specific context of the entire PPI network, i.e., its aging-specific subnetwork, by integrating aging-specific gene
expression data with PPI network data.
Indeed, the need for at least some level of data integration in the context of aging is being recognized. There exist
approaches for supervised prediction of aging-related genes that extract genes’ features from each of gene expression
data and PPI network data. These two feature types are then integrated by simply concatenating them [7, 8]. However,
clearly, methods of this type still extract features from each individual data type, i.e., they integrate the features rather
than the data. Consequently, they still consider the entire (static) PPI network.
Instead, we aim to first integrate the two data types and then extract node features from the resulting aging-specific
subnetwork. The potential of such true data integration has been recognized but in the context of cancer [22]. Only
one existing study [4], by our own group, inferred an aging-specific PPI subnetwork [23]. Specifically, given gene
expression data for 37 ages [14] and an entire (static) PPI network [23], 37 age-specific network snapshots were formed,
where each snapshot consists of all genes that are significantly expressed at the given age and all of their interactions.
That is, a given age-specific network snapshot was formed by taking the induced subgraph on the significantly expressed
genes at that age, which is why we refer to this aging-specific subnetwork inference approach as the induced approach.
Then, the 37 network snapshots were combined into a dynamic aging-specific PPI subnetwork, which captures how
network positions of genes change with age.
The goal of that study [4] was to infer the dynamic subnetwork, because the aging process is clearly dynamic. That
study [4] did also predict aging-related genes, but in an unsupervised manner, and primarily to validate the inferred
aging-specific subnetwork. On the other hand, our goal here is to rely on exactly the aging-specific subnetwork from
the existing study [4] (that is, we do not deal with the problem of subnetwork inference) and to develop on top of it a
comprehensive supervised framework for predicting aging-related genes (and recall that unsupervised and supervised
learning are different tasks). Also, the existing study [4] predicted a gene as aging-related if its network position
(namely, centrality) either significantly increased or decreased with age. As such, it would have missed any other types
of changes of genes’ network positions with age, such as network positions that continuously fluctuate or vary in a
non-linear fashion. On the other hand, supervised prediction allows for learning network position change patterns of
aging-related versus non-aging-related genes automatically from the data.
1.2 Our study and contributions
Unlike any of the existing studies, we present a supervised learning-based framework for predicting aging-related genes
from an aging-specific PPI subnetwork, AGENT (Figure 1).
Figure 1: Summary of AGENT and our study. Note that features 1-7 work only on the dynamic subnetwork. Features
8-10 work only on the static subnetwork and the entire static network. For details on each step of the study, see the text.
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We test three hypotheses: (1) whether using an aging-specific subnetwork improves the supervised prediction accuracy
compared to using the entire context-unspecific (static) network; (2) whether node features that are used in the task of
supervised prediction of aging-related genes for the first time in this study outperform the existing UniNet and mBPIs
features; and (3) because the aging process is dynamic, whether using the dynamic aging-specific subnetwork [4] is
superior to using its static version. To justify a need for our proposed AGENT framework, hypotheses 1 and 2 must
hold. Hypothesis 3 does not need to hold; its outcome has no affect on our study’s contributions. In fact, finding
that hypothesis 3, which by common sense is expected to be true, does not actually hold would be a more interesting
contribution of our study than finding that it does hold. We test our hypotheses as follows.
Because our goal here is not to propose a method for subnetwork inference, we rely on the existing aging-specific
subnetwork, which is dynamic [4]. Because we compare our proposed methods (see below) to the existing UniNet
and mBPIs methods that can use only a static network, we also consider a static version of the dynamic subnetwork
obtained by aggregating the PPIs from all age-specific snapshots of the dynamic subnetwork. We also consider the
entire context-unspecific (also static) PPI network from which the dynamic and static aging-specific networks are
obtained. Thus, the three networks are as fairly comparable to each other as possible.
Of 6,371 genes present in all three networks, we consider those present in GenAge [9] as aging-related; GenAge is
a confident ground truth knowledge about aging-related genes. Also, of the 6,371 genes, we consider as currently
non-aging-related those genes that are not in GenAge and that also satisfy the following. We are aware of five other
aging-related ground truth data [12–14, 16]. These are not as confident as GenAge, which is why we do not consider
their genes as aging-related in our study. However, they likely contain some true aging-related knowledge. We want our
non-aging-related genes to be as confident as possible, i.e., there should exist no current ground truth evidence of their
association to aging. So, we exclude all of the five data sets from what we consider as non-aging-related genes. The
above procedure results in 187 aging-related and 2,499 non-aging-related genes. It is possible that some of the 2,499
genes are actually aging-related; it is just that no current evidence of this exists. So, we aim to prioritize for future
experimental validation the 2,499 genes according to their likelihood of being aging-related.
For each aging-related and non-aging-related gene, we use eight features that, while not novel to our study, have not
yet been used in this study’s task of supervised prediction of aging-related genes. Among them, seven are dynamic,
i.e., extracted from the dynamic aging-specific subnetwork: dynamic graphlet degree vector (DGDV) [24], graphlet
orbit transitions (GoT) [25], graphlet degree centrality (GDC) [26], eccentricity (ECC), k-core (KC), degree centrality
(DegC), and centrality mean and variation (CentraMV) [4]. The remaining feature is static, i.e., extracted from the
static aging-specific subnetwork and the entire (also static) PPI network: static graphlet degree vector (SGDV) [27].
SGDV is DGDV’s fairly comparable static counterpart. Of the eight features, DGDV, GoT, GDC, and SGDV are
graphlet-based; graphlets are subgraphs (Lego-like building blocks) of a network. We use these features because
graphlets have been shown to be the state-of-the-art in many tasks [28] (but not yet in this study’s task). GDC, ECC,
KC, DegC, and CentraMV are centrality-based. These are dynamic counterparts of UniNet, against which we compare
our eight features; also, we compare against mBPIs. Just as the (dynamic or static) graphlet-based features, the dynamic
centrality-based features have not yet been used in this study’s task.
We couple each of our eight and the two existing features with nine prominent machine learning classifiers to make
aging-related gene predictions. For each feature, we aim to choose whichever classifier yields the most accurate
predictions. We evaluate each feature-classifier combination via 5-fold cross-validation: we train on a subset of our
aging- and non-aging-related genes and test prediction accuracy (favoring precision over recall) on the remaining aging-
and non-aging-related genes. Then, we compare the 10 considered features (each under its best classifier) in terms of
their prediction accuracy (as discussed above). Also, we compare them by measuring how many of their predictions
that are not in any of the considered aging-related ground truth data we can validate in cancer-related data, as cancer is
known to be highly related to aging [1].
To validate our hypothesis 1, it would suffice for the best feature on static or dynamic aging-specific subnetwork to
outperform every feature on the entire network. Indeed, this is what we find in both the 5-fold cross-validation and
validation on cancer data. Namely, the best-performing feature over all networks is SGDV on the static aging-specific
subnetwork.
To validate our hypothesis 2, it would suffice for one or more of our eight features on the dynamic or static aging-
specific subnetwork (depending on the feature) to be superior to both of the existing features on the static aging-specific
subnetwork (as these two can analyze only the static but not dynamic subnetwork). Indeed, this is what we find. Namely,
SGDV outperforms UniNet as well as mBPIs in both the 5-fold cross-validation and validation on cancer data. Also,
GoT and GDC outperform both UniNet and mBPIs in the 5-fold cross-validation (though not in the validation on cancer
data).
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Finally, we examine our hypothesis 3, which was already confirmed in an unsupervised analysis of the same aging-
specific subnetworks [24]. To validate it in our supervised analysis, it would suffice for the best feature on the dynamic
subnetwork to be superior to the best feature on the static subnetwork. Surprisingly, we find this (and thus hypothesis
3) not to hold. Namely, SGDV on the static subnetwork is the best of all features over all three networks, including
its dynamic counterpart – DGDV on the dynamic subnetwork. Implications of this unintuitive result are discussed in
Section 3.4. Importantly, we again note that the outcome of hypothesis 3 has no affect on our study’s contributions. The
other two hypotheses (1 and 2) that must hold have been shown to hold.
2 Methods
2.1 Data
2.1.1 The three considered networks
Table 1 shows sizes of: (i) the dynamic aging-specific PPI subnetwork, (ii) its corresponding static aging-specific PPI
subnetwork, and (iii) the entire (also static) context-unspecific PPI network. The latter is the network used to infer
the two aging-specific subnetworks in the first place [4], namely the PPI network from HPRD [23]. This allows for
a fair comparison of the three networks. Using a different (e.g., more recent) entire context-unspecific PPI network
would make it hard to fairly evaluate our hypotheses without having to infer the new corresponding aging-specific
subnetworks. Not only is this out of the scope of our study, but also, we have compared the entire context-unspecific
HPRD PPI network against a more recent (2019) entire context-unspecific BioGRID PPI network [29]. We have found
that for all considered static features (the only features that can be run on the two static networks), performance is better
on the HPRD network than on the BioGRID network. Throughout our study, we aim to give each feature the best-case
advantage. Clearly, the HPRD network is more advantageous. Thus, we do not further consider the BioGRID network.
Table 1: Sizes of the considered networks. The sizes for the dynamic subnetwork are the averages over its 37 snapshots.
Network # of nodes # of edges
Dynamic aging-specific subnetwork 4,696 15,062
Static aging-specific subnetwork 6,371 22,975
Entire static context-unspecific network 8,938 35,900
2.1.2 The six considered aging-related ground truth data sets
• Tacutu et al. [30] identified 307 human aging-related genes, mostly sequence orthologs of aging-related genes
in model organisms. Of these, 187 are present in all three networks and we denote them as GenAge; this is the
name of the trustworthy database they come from.
• Jia et al. [12] identified two sets of aging-related genes by studying the genotype-tissue expression project
(GTEx) data. One set includes 710 genes whose expressions are upregulated with age. Of these, 239 are
present in all three networks and we denote them as GTEx-UAG. The other set includes 863 genes whose
expressions are downregulated with age. Of these, 439 are present in all three networks and we denote them as
GTEx-DAG.
• Lu et al. [13] identified 442 genes whose expressions in the brain change with age. Of these, 303 are present
in all three networks and we denote them as BEx2004.
• Berchtold et al. [14] identified 8,277 genes whose expressions in the brain change with age. Of these, 2,918
are in all three networks and we denote them as BEx2008.
• Simpsom et al. [16] identified 2,911 genes whose expressions in the brain change across different stages of
Alzheimer’s disease. Of these, 1,162 are present in all three networks and we denote them as ADEx2011.
2.1.3 Aging-related genes and non-aging-related genes
Of the 6,371 genes present in all three networks, we treat the 187 GenAge genes as our aging-related genes. Of the 6,371
genes, we treat those 2,499 genes that are not in any of the six ground truth data sets as our non-aging-related genes.
2.1.4 Cancer-related genes
• Vogelstein et al. [31] identified 138 mutation-related cancer driver genes, i.e., genes whose intragenic mutations
contribute to cancer. Of these, 100 genes are present in both the aging-related and non-aging-related gene set
and we denote them as mutation driver genes.
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• Sondka et al. [32] identified 723 cancer driver genes by manually curating cancer-related genes from COSMIC
to determine the presence of somatic mutation patterns in cancer. Of these, 469 genes are present in both
the aging- and non-aging-related gene set. Combining the 469 genes with the 100 mutation driver genes, we
obtain 474 genes, which we denote as all driver genes. Clearly, the mutation driver genes are a subset of the
all driver genes.
2.2 Node features and classifiers
2.2.1 The 10 considered node features
• DGDV of a node [24] counts how many times the node participates in (touches) each dynamic graphlet on
up to n nodes and e events (temporal edges), i.e., in each of the given graphlet’s topologically unique node
positions called automorphism orbits. Dynamic graphlets are an extension of static graphlets, i.e., up to n-node
subgraphs of a static network, to the dynamic setting, with temporal information added onto edges of static
graphlets; this information indicates the temporal order in which events occur in a dynamic network. When we
compute DGDV, we consider up to 4-node and 6-event graphlets, as suggested in the DGDV publication [24],
which have 3,727 orbits.
• GoT [25] is another dynamic extension of static graphlets. GoT of a node counts how many times the node’s
participation in one graphlet (e.g., a triangle) changes to its participation in another graphlet (e.g., a 3-node
path, when an edge of a triangle “breaks”) between every two consecutive time points, and for every pair of
considered graphlets (i.e., their orbits). When we compute GoT, we consider 4-node graphlets, as done in the
GoT publication [25], and to make GoT fairly comparable to DGDV. This results in examining 11 orbits and
thus 121 orbit pairs.
• GDC of a node [26] is a weighted sum of the counts of all graphlets on up to n nodes (i.e., their orbits) in
which the node participates, where the weights account for orbit dependencies (see the GDC publication [26]
for details). According to GDC, the more (larger and denser) graphlets a node touches, the more complex its
extended network neighborhood, and so the more central it is.
This definition of GDC is for a static network. We use such GDC to compute, for each node, its centrality
in each of the 37 snapshots of the dynamic subnetwork. Then, we combine a given node’s 37 GDC values into
its 37-dimensional dynamic GDC feature. We do the same for the other centrality features below (ECC, KC,
and DegC), each resulting in a 37-dimensional node feature.
For all other graphlet-based features (DGDV, GoT, and SGDV), we consider up to 4-node graphlets. For
GDC, we have to use up to 5-node graphlets. This is because the GDC code that we used, which originates
from [4], is an executable only that is a part of a larger software. The latter does not allow for specifying the
desired graphlet size; instead, it uses up to 5-node graphlets by default. If anything, this should only give
advantage to GDC over the other graphlet features, because more of network topology is captured when also
using 5-node graphlets. Yet, as we show in Section 3, GDC is not the best graphlet feature.
• ECC of a node [4] is the reciprocal of the shortest path distance from the node in question to the farthest of all
other nodes in the network.
• KC of a node [4] is based on the notion of a network core. A core of a network is a subgraph in which each
node is connected to at least k other nodes in the subgraph. So, a network has its 1-core, its 2-core, its 3-core,
etc. KC of a node is k if the node is in the k-core.
• DegC of a node [4] is the number of edges it touches.
• CentraMV [4] works as follows. For a given centrality-based feature (out of GDC, ECC, KC, and DegC), the
mean and the corresponding variation are computed over a given node’s 37 centrality values corresponding
to the 37 snapshots of the dynamic subnetwork. The mean is self-explanatory, and the variation of node
u is var(u) =
∑36
i=1(centrality(u)i+1 − centrality(u)i)/36, i = 1, 2, ..., 36. These two quantities are
computed for each of the four centrality-based features, and the resulting eight values form the CentraMV
node feature.
• SGDV of a node [27] counts, for each static graphlet on up to n nodes, how many times the node participates
in the given graphlet (i.e., in each of its orbits). When we compute SGDV [33], for a fair comparison with
DGDV, we use up to 4-node graphlets, which encompass 15 orbits.
• UniNet’s feature [8] combines 14 node centralities: DegC, ECC, KC, average shortest path, betweenness,
closeness, clustering coefficient, neighborhood connectivity, radiality, stress, topological coefficient, aging
neighbor count, aging neighbor ratio, and binary aging neighbor representations (for details, see the UniNet
publication [8]).
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• The feature of mBPIs [7] is defined in Section ??. We have evaluated three m values, 10, 20, and 30, as
suggested in the mBPIs paper [7]. Because we have found that m = 30 performs the best, we only report
results for this value of m and henceforth refer to mBPIs as 30BPIs.
Some of the considered features, especially DGDV and GoT, have high dimensions. High dimensionality of a feature
can lead to its overfitting during classification [34]. Because of this, and as typically done [11, 24, 35], we have applied
principal component analysis (PCA) to reduce the feature dimensions, while considering as few PCA components as
needed to account for at least 90% of variation. We have found that for DGDV and GoT, their post-PCA versions are
more accurate than their pre-PCA versions. To give DGDV and GoT the best-case advantage, and because for the
other considered features we have not seen any major accuracy differences between their pre- and post-PCA versions,
henceforth we consider only the post-PCA versions of all considered features (Table 2).
Table 2: Pre- and post-PCA dimensions of the considered features (red: dynamic; blue: static; underlined: existing).
DGDV GoT GDC ECC KC DegC CentraMV SGDV UniNet 30BPIs
Pre-PCA 3,727 121 37 37 37 37 8 15 18 30
Post-PCA 2 2 5 12 5 1 1 2 1 24
2.2.2 The nine considered classifiers
Adaptive Boosting (AdaBoost), Random Forest (RF), and Decision Tree (Dtree) combine a set of trees to improve
classification performance. Logistic Regression (LR) uses a logistic function to model a binary dependent variable.
Naïve Bayes (NB) is a family of “probabilistic classifiers” that apply Bayes’ theorem assuming that the features are
independent. We use Gaussian NB, which extends the traditional NB to handle real-valued features. K-Nearest
Neighbors (KNN) is a non-parametric method that assigns an object to the class that is the most common among its K
nearest neighbors. Support Vector Machine (SVM) outputs an optimal hyperplane by using the hinge loss function to
categorize objects. It can be used with multiple kernel functions based on whether the objects are linearly separable. We
use both a linear (SVM-linear) and non-linear kernel (radial basis function (SVM-rbf)). Multilayer Perceptron (MLP)
is a class of feedforward artificial neural network that can classify objects when they are not linearly separable.
We implement the classifiers in scikit-learn (version 0.20.3) [36], a public machine learning library for Python. We use
the classifier’s default parameter values. For some parameters (e.g., K in KNN), we have tested several values around
the default value. The default value (i.e., K = 5 in KNN) is the best.
2.3 Evaluation and validation
2.3.1 Evaluation via 5-fold cross-validation and prediction accuracy measures
For each of the 187 aging- and 2,499 non-aging-related genes and each of their 10 features that are extracted from
the corresponding networks, we train and test each of the nine classifiers using 5-fold cross-validation. Namely, we
randomly divide each of the aging- and non-aging-related gene sets into five equal-sized subsets. Then, we train a
classifier on the union of four aging- and four non-aging-related gene subsets and test on the union of one aging- and one
non-aging-related subset. We repeat this five times so that each time we are using a different subset as the testing data.
The output is a probability of each gene being aging-related. We predict the top g most probable genes as aging-related,
where we vary g from 1 to 60 in increments of 2 and then from 60 to 500 in increments of 10. 500 is the approximate
size of a testing data set (i.e., of a predicted set) in each fold.
Given a prediction set and the set of our aging-related genes (GenAge), a true positive (TP) is a gene that is in GenAge
and is predicted as aging-related, a false positive (FP) is a gene that is not in GenAge but is predicted as aging-related,
and a false negative (FN) is a gene that is in GenAge but is not predicted as aging-related. In our data, there are more
non-aging- than aging-related genes. So, we use the above quantities to calculate three popular prediction accuracy
measures that can deal with such imbalanced data: precision, recall, and F1-score, each averaged over the five runs of
the cross-validation.
These measures are computed for each prediction set, i.e., at each value of g. We could summarize the performance of a
feature-classifier combination over the entire g range via the area under the precision-recall curve (AUPR). However,
we instead want to give each combination the best-case advantage, by selecting a specific value of g that results in the
most accurate predictions over all g values. Also, importantly, using AUPR would not produce a specific predicted gene
set for further analysis. To produce such a set, we need to choose a specific value of g. Choosing a best-case value of g
is non-trivial, as there is a trade-off between precision and recall. We believe that a meaningful value of g is the one
where F1-score (which balances between precision and recall) is maximized.
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We compare the prediction accuracy of each feature-classifier combination with that of a random approach, which
works as follows. For a given testing data set and a given g value, we randomly select g genes from the testing data and
predict them as aging-related. Then, we calculate prediction accuracy (precision, recall, and F1-score). We do this for
the testing data in each of the five folds. We repeat the above procedure 30 times, to account for its randomness. This
results in 5× 30 = 150 random runs. For the random approach, we report its prediction accuracy averaged over the
150 runs.
For a prediction accuracy measure, given two feature-classifier combinations (i.e., five prediction accuracy values for
each combination resulting from the five folds), we compute the statistical significance (i.e., p-value) of the difference
in their prediction accuracy via the paired Wilcoxon rank sum test. Since we run this test multiple times, we apply false
discovery rate (FDR) correction to adjust the p-values.
2.3.2 Selection of the best classifier for each feature
For a feature, we select as its best classifier the one that maximizes precision at the g value where F1-score is maximized
(see above). We favor precision over recall because we believe that in biomedicine, for wet lab validation of predictions,
it is more important to have say nine correct predictions out of 10 made than say 30 correct predictions out of 100 made.
While in the latter case many more are correct (30 vs. nine), which would likely yield a higher (approximately triple)
recall, in the latter case also many more are incorrect (70 vs. only one), which results in a lower precision (0.3 vs. 0.9).
While we favor higher precision, at the same time, recall should not decrease too much. This is exactly why we choose
the g value where F1-score is maximized – in Section 3, we verify that this choice results in a high recall as well.
2.3.3 Validation of newly predicted genes on cancer data
We denote as newly predicted those genes that are predicted as aging-related (by a given feature under its best classifier)
but are not present in any of the six aging-related ground truth data sets. Because aging and cancer are known to be
tightly linked [1], the more of the newly predicted genes are present in the cancer-related data, the more accurate the
predictions.
2.3.4 Overlap between prediction sets
We use the Jaccard index (J) [37] to measure the size of the overlap between two prediction sets A and B: |A∩B||A∪B| . The
lower its value, the more complementary sets A and B are. We evaluate the statistical significance (i.e., p-value) of the
given overlap size via the hypergeometric test. Since we run this test multiple times, we apply FDR correction to adjust
the p-values.
3 Results and discussion
3.1 Selecting the best classifier for each feature
First, we comment on our classifier selection criterion. Recall that for each feature, we select as its best classifier the
one that maximizes precision at prediction threshold value g where F1-score is maximized.
We believe that favoring precision over recall at this g value is meaningful, because each feature’s best classifier should
maximize precision without lowering recall much. To verify this, we examine what the difference would be if we
instead maximized recall at the same g value. We find that for four of the 10 features, the classifier that maximizes
precision also maximizes recall. For four of the remaining six features, the drop in recall of the classifier that maximizes
precision compared to the classifier that maximizes recall is less than 10% of the latter’s recall (results not shown due to
space constraints). So, overall, the drop in recall is small, as desired.
Also, we believe that, out of all considered values of g, focusing on value g where F1-score is maximized is meaningful.
To verify this, for each feature, we also consider value g where precision and recall cross, as well as AUPR over the
entire g range. Then, we aim to identify the best of all classifiers with respect to all of these criteria as a whole. We find
that for five of the 10 features, the best classifier selected this way matches the one selected via the above criterion
(results not shown).
Second, we comment on selected classifiers. Up to three features share the same best classifier (Table 3). So, the choice
of classifier seems to matter. Yet, the effect of this choice does not seem to be major. For each of the 10 features,
when run on its corresponding aging-specific subnetwork, we analyze the given feature’s top three best-performing
classifiers. That is, we measure the overlap of the three classifiers’ predicted genes. We find that the three classifiers are
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predicting similar sets of genes. That is, on average over all features, the best classifier covers 81% of the predictions
made by the second best and third best classifiers, while at the same time its unique predictions are more accurate (since
it maximizes precision over all classifiers). The predictions of the different classifiers being consistent, combined with
us choosing the most precise of all classifiers, justifies our classifier selection criterion.
Henceforth, we analyze each feature under its best classifier.
Table 3: The selected (best) classifier for each feature.
DGDV GoT GDC ECC KC DegC CentraMV SGDV UniNet 30BPIs
AdaBoost RF RF MLP SVM-rbf AdaBoost RF LR LR LR
3.2 Using an aging-specific subnetwork is superior to using the entire context-unspecific network
Here (hypothesis 1), where we analyze the two aging-related subnetworks and the entire context-unspecific network,
we perform evaluation via the 5-fold cross validation, focusing mainly on precision (for reasons discussed in Section
2.3; all features still have a reasonably high recall). In the following sections (hypotheses 2 and 3), where we focus only
on the two aging-related subnetworks, we perform evaluation via both the 5-fold cross validation and validation on the
cancer data.
To validate hypothesis 1, it would suffice for the best feature on the dynamic or static aging-specific subnetwork to
outperform every feature on the entire network. Indeed, we find this to hold: SGDV on the static subnetwork has the
highest precision of all features on all networks (Figure 2). Its superiority is not significant compared to UniNet and
BPIs on the entire network, but its superiority is significant compared to SGDV on the entire network (adjusted p-value
of 0.047).
3.3 Our proposed features outperform the existing features
To validate hypothesis 2, it would suffice for one or more of our eight features on the dynamic or static aging-specific
subnetwork to be superior to both of the existing features on the static aging-specific subnetwork. Indeed, we find this
to be the case. In the 5-fold cross-validation (Figure 2), of all considered features, three of our graphlet-based features
(i.e., SGDV, GoT, and GDC) have higher precision than both UniNet and 30BPIs, although we note that their superiority
is not statistically significant. Further, in the cancer-related validation (Figure 3), a larger fraction of our SGDV’s newly
predicted genes are among all driver genes and mutation driver genes (29% and 12%, respectively) than of UniNet’s
newly predicted genes (17% and 8%, respectively) and of 30BPIs’s newly predicted genes (22% and 9%, respectively).
Note that this is despite the fact that UniNet uses aging-related information not just in the training stage of the
classification process but also in the feature itself (unlike any other considered feature). This should give advantage to
UniNet, but it does not based on the results, which implies that the network topological part of its feature may be weak.
Figure 2: Prediction accuracy of all considered features (each under the best classifier) over all considered networks,
plus the random approach. The seven dynamic features can be run only on the dynamic subnetwork. The three static
features can be run on both the static subnetwork and the entire network. For convenience, we show the precision values
on top of the bars.
8
Figure 3: Validation of each feature’s newly predicted genes via all driver genes or only mutation driver genes. In this
analysis, each feature is run on its corresponding (either dynamic or static) aging-specific subnetwork (i.e., the entire
context-unspecific network is not considered). The left y-axis shows: the number of newly predicted genes (blue bar);
of these, the number of all driver genes (red bar); of these, the number of mutation driver genes (cyan bar). The right
y-axis shows the fraction of the newly predicted genes that are: all driver genes (red line) and mutation driver genes
(cyan line).
Importantly, all features perform significantly better than at random (adjusted p-values ≤ 0.016), while at the same
time, each of them is far from perfect (Figure 2). Moreover, when we compare overlaps of the true positive (i.e., actual
aging-related) gene predictions of the different features, we find that while all overlaps are statistically significantly
high (adjusted p-values ≤ 3.8 × 10−6), their sizes are only between 37% and 75%, depending on the compared
features; the average overlap size over all feature pairs is 56%. Thus, the different features’ predictions are reasonably
complementary to each other. This could be because the features capture somewhat complementary aspects of network
topology. So, developing a new (e.g., ensemble learning) approach that would combine their complementary topological
aspects might be promising.
Because the different features are complementary, we combine all of their newly predicted genes. Of these, we consider
those 29 genes that are cancer driver genes to be good targets for wet lab validation by the community (Table 4).
Table 4: The 29 newly predicted genes across all considered features that are also cancer driver genes. Of these,
mutation cancer driver genes are bolded. In parentheses is the number of features that support a prediction. The genes
are listed in alphabetical order (left to right, then top to bottom).
ARAF(1) BTK(2) CASP9(6) CCND1(4) CIC(1)
CTCF(1) DAXX(3) DDX5(1) EIF3E(1) EZR(2)
FBXO11(1) HIP1(1) HSP90AB1(1) IRS4(3) KAT7(2)
KDR(7) LEF1(2) NCOA3(9) PABPC1(5) REL(1)
RHOA(1) SEPT9(1) SMAD2(10) SMAD4(8) SRSF3(1)
TSC1 (1) VAV1(2) WAS(4) ZEB1(1)
3.4 Using the dynamic aging-specific subnetwork does not improve compared to using the static
aging-specific subnetwork
To validate hypothesis 3, it would suffice for the best feature on the dynamic subnetwork to be superior to the best
feature on the static subnetwork. However, we find this not to be the case. The static SGDV has a higher precision in
the 5-fold cross validation (Figure 2) and a higher cancer-data validation rate (Figure 3) than any dynamic feature. Even
though our dynamic features do not outperform SGDV, we remind that the dynamic features’ predictions complement
those of SGDV, i.e., they have a potential to identify novel aging-related genes that the static feature might miss. In fact,
the dynamic features combined do predict 17 true positives (i.e, known aging-related genes) that SGDV misses.
Nonetheless, the above result is shocking, and examining its cause(s) is important. This is the subject of future work. A
reason for it could be that the current dynamic aging-specific subnetwork is suboptimal, as it is constructed using the
induced approach [4], meaning that all edges between significantly expressed genes at a given age are considered. More
recently, the notion of network propagation was introduced as a better alternative, but for inference of only a static
context-specific subnetwork, and mainly in the context of cancer [38]. Network propagation diffuses gene activities
(expression levels) over the entire network to assign context-specific weights to its edges, and then it uses only the
highest-weight edges to form a static context-specific subnetwork. Because current network propagation cannot infer a
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dynamic subnetwork, we cannot consider it in this study. In fact, developing a novel network propagation approach for
inference of a dynamic aging-specific subnetwork is the subject of our on-going work that is beyond the scope and
timeline of this study. Note that considering a static network propagation-based aging-specific subnetwork in this study
is unnecessary, because it could not help with testing our hypothesis 3. Instead, it could “only” further strengthen our
hypotheses 1 and 2, which we have already proven. And it is hypotheses 1 and 2 that are necessary and sufficient to
justify the need for introducing our AGENT framework.
4 Conclusions
In this paper, we propose a new supervised framework called AGENT that utilizes node features extracted from an
aging-specific PPI subnetwork in the context of classification to predict human aging-related genes. In a fair and
comprehensive evaluation, we show that our framework results in higher prediction accuracy than existing state-of-the-
art methods for the same purpose that use an entire, context-unspecific PPI network. While in this paper we focus on
human aging, our work can easily be applied to other species. Also, while we focus on PPI networks, our work can
easily be applied to other types of biological networks.
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